| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |